See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2023_Agile_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001261249, Agile Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,358,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 177,000 |
| 3 | remainder_Assets | 2,707,000 |
| 4 | LiabilitiesCurrent | 13,387,000 |
| 5 | LiabilitiesNoncurrent | 466,000 |
| 6 | remainder_Liabilities | 5,934,000 |
| 7 | CostOfGoodsAndServicesSold | 7,835,971 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,513,323 |
| 9 | ResearchAndDevelopmentExpense | 1,734,597 |
| 10 | remainder_Expenses | 33,467,735 |
| 11 | remainder_Revenues | 44,789,565 |
| 12 | remainder_NetIncome | -3,691,399 |
| 13 | remainder_ComprehensiveNetIncome | -1,710 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,242,000 |
| 1 | Liabilities | 19,787,000 |
| 2 | Expenses | 54,551,626 |
| 3 | Revenues | 44,789,565 |
| 4 | StockholdersEquity | -5,545,000 |
| 5 | NetIncome | -13,453,460 |
| 6 | ComprehensiveNetIncome | -13,454,315 |
| 7 | BaseVar | 68,531,650 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.50 |
| 9 | EconomicCapitalRatio | 1.18 |
Edgar->Model Mapping
Feature Distribution
Change over Time
